Metraipolis › archive › dc_f7f2f284e6ef

Opinion: Gavage Administration of MXene as a Route-Specific Alternative to Intravenous Injection into the Bloodstream of Laboratory Animals for Reducing… — Europe PMC PMID:41848606

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41848606
DOI
10.1002/adhm.71055
License (as archived)
solo-consultazione
Archived
2026-10-08T03:54:04.755Z
SHA-256 of the archived text
d537c0000bb03158b5a5799c47f8996d97aad10e7667b1558763dc787e9ef652
Stable URL of this page
https://metraipolis.com/documento/dc_f7f2f284e6ef

How to cite

Opinion: Gavage Administration of MXene as a Route-Specific Alternative to Intravenous Injection into the Bloodstream of Laboratory Animals for Reducing… — Europe PMC PMID:41848606 — Europe PMC (en), https://europepmc.org/article/MED/41848606 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f7f2f284e6ef (Metraipolis archive dc_f7f2f284e6ef, sha256 d537c0000bb03158b5a5799c47f8996d97aad10e7667b1558763dc787e9ef652)
BibTeX
@misc{dcf7f2f284e6ef,
  title = {Opinion: Gavage Administration of MXene as a Route-Specific Alternative to Intravenous Injection into the Bloodstream of Laboratory Animals for Reducing… — Europe PMC PMID:41848606},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41848606},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f7f2f284e6ef; sha256 d537c0000bb03158b5a5799c47f8996d97aad10e7667b1558763dc787e9ef652},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41848606. Agents can read the archived copy with the MCP tool read_document.